Cube Psytech Holdings

Canadian biopharma psychedelics company Cube Psytech Holdings agreed to acquire Translational Life Sciences (TLS).  Cube will issue about 50% of its outstanding shares, warrants and options to shareholders, directors and employees of TLS in exchange for 100% of its outstanding share capital....